«
»

Stock management of pharmaceuticals – ECJ to toughen its stance?

An analysis of Advocate General Ruiz-Jarabo’s opinion in a case involving GlaxoSmithKline’s stock management policy of certain drugs in Greece, recently released by the European Court of Justice.

Tags: , , , ,

This entry was posted on April 4, 2008 at 6:29 pm and is filed under European. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out / Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

Follow

Get every new post delivered to your Inbox.